Literature DB >> 2782396

Phallacidin prevents thrombin-induced increases in endothelial permeability to albumin.

P G Phillips1, H Lum, A B Malik, M F Tsan.   

Abstract

Calf pulmonary artery endothelial monolayers cultured on polycarbonate filters were utilized to study 125I-labeled albumin permeability and actin filament distribution in response to thrombin challenge. Thirty-minute exposure to alpha-thrombin (10(-7) M) significantly increased albumin clearance rates. These changes were associated with marked alterations in actin filament distribution, resulting in loss of peripheral actin bands and an increase in the number of cytoplasmic stress fibers. Because the actin peripheral filaments are thought to play an important role in junctional stability, we postulated that stabilization of actin filaments should protect against thrombin-induced barrier disruptions. Pretreatment of cells with 0.3 microM 7-nitrobenz-2-oxa-1,3-diazole (NBD)-phallacidin, a specific actin-stabilizing agent, prevented the changes in actin filament distribution and markedly attenuated the increase in albumin permeability. Because of the potential toxicity of phallatoxins, we evaluated the effects of pretreatment on cell viability and growth parameters. There were no differences in viability, seeding efficiency, or doubling times in cells treated with 0.3 microM NBD-phallacidin in comparison to controls. Our data support the hypothesis that actin filaments, particularly peripheral bands, contribute significantly to the maintenance of barrier function in cultured endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2782396     DOI: 10.1152/ajpcell.1989.257.3.C562

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

Review 1.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

2.  Stabilization of F-actin prevents cAMP-elicited Cl- secretion in T84 cells.

Authors:  M Shapiro; J Matthews; G Hecht; C Delp; J L Madara
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Soluble adenylyl cyclase-dependent microtubule disassembly reveals a novel mechanism of endothelial cell retraction.

Authors:  Nutan Prasain; Mikhail Alexeyev; Ron Balczon; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-04-24       Impact factor: 5.464

Review 4.  Receptor tyrosine kinase inhibitors in rodent pulmonary hypertension.

Authors:  Liliana Moreno-Vinasco; Joe G N Garcia
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Ceramide alters endothelial cell permeability by a nonapoptotic mechanism.

Authors:  Karsten Lindner; Ulrike Uhlig; Stefan Uhlig
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

6.  HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption.

Authors:  Rachel K Wolfson; Eddie T Chiang; Joe G N Garcia
Journal:  Microvasc Res       Date:  2010-12-10       Impact factor: 3.514

7.  Cellular repressor of E1A stimulated genes enhances endothelial monolayer integrity.

Authors:  Yan Duan; Shaowei Liu; Jie Tao; Yang You; Guitang Yang; Chenghui Yan; Yaling Han
Journal:  Mol Biol Rep       Date:  2013-04-12       Impact factor: 2.316

8.  Endocardial endothelium in the rat: cell shape and organization of the cytoskeleton.

Authors:  L J Andries; D L Brutsaert
Journal:  Cell Tissue Res       Date:  1993-07       Impact factor: 5.249

9.  SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function.

Authors:  S E Goldblum; X Ding; S E Funk; E H Sage
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

10.  Overexpression of actin-depolymerizing factor blocks oxidized low-density lipoprotein-induced mouse brain microvascular endothelial cell barrier dysfunction.

Authors:  Jun Wang; Lu Sun; Yan-Fang Si; Bao-Min Li
Journal:  Mol Cell Biochem       Date:  2012-08-29       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.